Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) has issued an update.
MicroPort CardioFlow Medtech Corp. has announced the composition of its board of directors, highlighting the roles and functions of each member. This announcement provides clarity on the company’s leadership structure, which is crucial for its strategic direction and operational efficiency, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (HK:2160) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on MicroPort CardioFlow Medtech Corp. stock, see the HK:2160 Stock Forecast page.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corp. is a company incorporated in the Cayman Islands, focusing on the medical technology industry. It specializes in cardiovascular devices and related services, aiming to address the needs of patients and healthcare providers in the cardiovascular sector.
Average Trading Volume: 5,283,651
Technical Sentiment Signal: Hold
Current Market Cap: HK$2.77B
For detailed information about 2160 stock, go to TipRanks’ Stock Analysis page.